In recent years, a retrospective multicenter data analysis of gastric cancer with BRCA1 or BRCA2 germline mutations (gBRCAm) was conducted to identify 10 gastric cancer patients with gBRACm, 6 of whom had metastatic disease. This evidence concerns the gene BRCA2 and gastric cancer.